Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat ...
Improving the therapeutic quality and consistency of cell and gene therapies requires the adoption of enhanced Critical Quality Attributes (CQAs) throughout the development and manufacturing processes ...
The UCSF Life Sciences Building will have eight floors above ground and two levels below, which will house a proton therapy center. Primary care and multi-specialty clinics will occupy floors two ...
Laboratory assessments — from preclinical research through post-marketing surveillance — determine whether a cell-based therapy for cancer succeeds or fails. “Every developer out there advancing CAR T ...
CAMBRIDGE, UK--(BUSINESS WIRE)--bit.bio, the company coding human cells for novel cures, today announced its cell therapy pipeline and declared its lead cell therapy candidate as it prepares to enter ...
Emily Whitehead made the history books in 2012 when she become the first pediatric patient with B-cell acute lymphoblastic leukemia to be given a chimeric antigen receptor (CAR) T-cell therapy. After ...
Connecticut cancer patients will soon have access to the most advanced form of radiation therapy, due to a collaboration between Hartford HealthCare and Yale New Haven Health. On Oct. 24, leaders from ...
insights from industryDr. Ramin Baghirzade Global Head of Commcerical - Gene Therapy Charles River Laboratories In this interview conducted at the Cell and Gene Therapy Summit Tour London, we speak to ...
Visiting Nassau County on Tuesday, Gov. Kathy Hochul announced plans for the New York BioGenesis Park, a $430 million, 700,000-square-foot cell and gene therapy (CGT) hub in Lake Success. Developed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback